Anders Essen-Möller

Anders Essen-Möller

Founder at DIAMYD MEDICAL AB

Net worth: 3 M $ as of 2024-04-29

83 year
Health Technology
Finance
Technology Services

Profile

Mr. Anders Essen-Möller is a Chairman at Diamyd Medical AB.
He is on the Board of Directors at Armea AB, Companion Medical, Inc. and Diamyd Diagnostics AB.
Mr. Essen-Möller was previously employed as a Chief Executive Officer & Director by Synectics Medical AB and a Chairman by NextCell Pharma AB.
He also served on the board at Kancera AB and Mertiva AB.
He received his graduate degree from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-24 2,957,040 ( 3.21% ) 3 M $ 2024-04-29
2023-08-30 556,223 ( 21.76% ) 541 227 $ 2024-04-29

Anders Essen-Möller active positions

CompaniesPositionStart
DIAMYD MEDICAL AB Founder 1995-12-31
Diamyd Diagnostics AB Director/Board Member 2011-05-09
Armea AB Director/Board Member 2011-05-09
Director/Board Member -
All active positions of Anders Essen-Möller

Former positions of Anders Essen-Möller

CompaniesPositionEnd
NEXTCELL PHARMA AB Chairman 2024-05-19
Founder 2016-04-09
MERTIVA AB Founder 2014-02-20
KANCERA AB Director/Board Member 2012-03-27
See the detail of Anders Essen-Möller's experience

Training of Anders Essen-Möller

University of Lund Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anders Essen-Möller's experience

Connections

52

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
KANCERA AB

Health Technology

DIAMYD MEDICAL AB

Health Technology

NEXTCELL PHARMA AB

Health Technology

Private companies5

Health Technology

Finance

Technology Services

Diamyd Diagnostics AB

Armea AB

See company connections
  1. Stock Market
  2. Insiders
  3. Anders Essen-Möller